Peter R. Herman is a shareholder at Wilentz, Goldman & Spitzer, P.A. and co-chair of the firm’s Banking & Financial Services group and the Bankruptcy and Creditors' Rights group. For over 30 years, he has represented both lending institutions and business entities in a broad range of commercial finance transactions, including those related to secured and unsecured lending, asset-based lending, letters of credit, tax-exempt financing, syndicated and club transactions, mezzanine financing, participations, construction financing, merger and acquisition financing, sponsor deals, and loan workout restructuring. Mr. Herman’s banking and corporate law practice also includes representing companies in the real estate, healthcare, manufacturing, and service industries with regard to both national and international transactions.

Since 2004, Mr. Herman has been consistently selected for inclusion in Best Lawyers in America for Banking and Finance Law. In addition, he has been recognized as a leading finance lawyer by Super Lawyers.

*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance.  Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity.  Compliance with state marijuana law does not equal compliance with federal law.  Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.

  • Representation of a national association of fertility clinics as outside counsel in connection with its partial merger with a global medical institution in the field of reproductive endocrinology, forming the world’s largest assisted reproduction group with estimated combined enterprise value of over $1 billion.
  • Representation of a multinational financial institution in connection with a three tranche credit facility aggregating in excess of $150 million for a leading convenience store and gas station chain to fund its working capital needs and its acquisition of new facilities in New Jersey, New York and elsewhere.
  • Representation of a full-service community bank with extensive branch network in preparing and negotiating documentation for a $23 million asset-based revolving loan and a $12.5 million equipment acquisition facility.
  • Representation of a senior living community provider in connection with a tax-exempt and conventional credit facility aggregating in excess of $100 million.
 

Also of Interest